Tag: Ivosidenib

Promising results for ivosidenib-based triplet therapy in IDH1-mutated malignancies

Presented By
Dr Jennifer Marvin-Peek, MD Anderson Cancer Center, TX, USA
Trial
Phase 1/2
Conference
ASH 2024
Type
Peer-reviewed article

29 January 2025 10:12

Ivosidenib in second-line improves OS in IDH1-mutant cholangiocarcinoma

Presented By
Dr Andrew Zhu, Harvard Medical School, USA
Trial
Phase 3, ClarIDHy
Conference
ASCO GI 2021
Type
Peer-reviewed article

12 March 2021 11:46

IDH1+ cholangiocarcinoma: phase 3 results show improved PFS

Presented By
Dr Ghassan Abou-Alfa, Memorial Sloan-Kettering Cancer Center, New York, USA
Trial
Phase 3, ClarIDHy
Conference
ESMO 2019
Type
Peer-reviewed article

26 November 2019 17:22
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com